REPLIGEN CORP (RGEN) capitalization

Current snapshot

Market Cap
$6.65B
56.4M shares × $117.82 · as of last filing 2026-03-31
Net Worth
$2.11B
Stockholders' equity · 2026-03-31
Enterprise Value
$6.55B
Market cap + debt − cash
Net Debt
-$96.9M
Debt $687.6M − Cash $784.5M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $9.27B
FY'24 2024-12-31 $8.05B
FY'23 2023-12-31 $10.14B
FY'22 2022-12-31
FY'21 2021-12-31 $15.17B
FY'20 2020-12-31 $10.33B
FY'19 2019-12-31 $4.55B
FY'18 2018-12-31 $2.40B
FY'17 2017-12-31 $1.42B
FY'16 2016-12-31 $1.05B
FY'15 2015-12-31 $949.9M
FY'14 2014-12-31 $658.6M
FY'14 2014-06-02
FY'13 2013-12-31 $442.0M
FY'12 2012-12-31 $196.3M
FY'12 2011-12-31 $106.8M
FY'11 2011-03-31 $115.1M
FY'11 2010-12-31 $145.2M
FY'11 2010-03-31 $124.9M

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $6.68B
Q4'25 2025-12-31 $9.23B
Q3'25 2025-09-30 $7.56B
Q2'25 2025-06-30 $7.03B
Q1'25 2025-03-31 $7.20B
Q4'24 2024-12-31 $8.07B
Q3'24 2024-09-30 $8.34B
Q2'24 2024-06-30 $7.11B
Q1'24 2024-03-31 $10.40B
Q4'23 2023-12-31 $10.03B
Q3'23 2023-09-30 $9.05B
Q2'23 2023-06-30 $8.04B
Q1'23 2023-03-31 $9.60B
Q4'22 2022-12-31 $9.41B
Q3'22 2022-09-30 $10.72B
Q2'22 2022-06-30 $9.21B
Q1'22 2022-03-31
Q4'21 2021-12-31 $14.65B
Q3'21 2021-09-30 $16.58B
Q2'21 2021-06-30 $11.34B
Q1'21 2021-03-31 $11.06B
Q4'20 2020-12-31 $10.49B
Q3'20 2020-09-30 $7.89B
Q2'20 2020-06-30 $6.59B
Q1'20 2020-03-31 $5.13B
Q4'19 2019-12-31 $4.82B
Q3'19 2019-09-30 $3.97B
Q2'19 2019-06-30 $4.22B
Q1'19 2019-03-31 $2.73B
Q4'18 2018-12-31 $2.32B
Q3'18 2018-09-30 $2.54B
Q2'18 2018-06-30 $2.12B
Q1'18 2018-03-31 $1.60B
Q4'17 2017-12-31 $1.58B
Q3'17 2017-09-30 $1.63B
Q2'17 2017-06-30 $1.45B
Q1'17 2017-03-31 $1.21B
Q4'16 2016-12-31 $1.04B
Q3'16 2016-09-30 $1.04B
Q2'16 2016-06-30 $935.0M
Q1'16 2016-03-31 $898.3M
Q4'15 2015-12-31 $932.1M
Q3'15 2015-09-30 $938.3M
Q2'15 2015-06-30 $1.39B
Q1'15 2015-03-31 $1.02B
Q4'14 2014-12-31 $648.9M
Q3'14 2014-09-30 $663.5M
Q2'14 2014-06-30 $753.8M
Q4'14 2014-06-02
Q1'14 2014-03-31 $409.7M
Q4'13 2013-12-31 $435.5M
Q3'13 2013-09-30 $361.0M
Q2'13 2013-06-30 $266.3M
Q1'13 2013-03-31 $220.1M
Q4'12 2012-12-31 $195.9M
Q3'12 2012-09-30 $186.3M
Q2'12 2012-06-30 $133.9M
Q1'12 2012-03-31 $183.0M
Q4'12 2011-12-31 $106.6M
Q3'11 2011-09-30 $100.8M
Q2'11 2011-06-30 $112.2M
Q4'11 2011-03-31 $115.2M
Q3'11 2010-09-30 $104.5M
Q2'11 2010-06-30 $99.3M

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (RGEN CIK 0000730272), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

ATMU

Atmus Filtration Technologies Inc.

HIMS

HIMS & HERS HEALTH, INC.

REGN

REGENERON PHARMACEUTICALS, INC.